Tham See Wan, Li Li, Effraim Philip, Waxman Stephen
Seattle Children's Research Institute, Seattle, Washington, USA.
Department of Anesthesia and Pain Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
BMJ Case Rep. 2017 Jul 26;2017:bcr-2017-219486. doi: 10.1136/bcr-2017-219486.
Inherited erythromelalgia (IEM) is a well-described pain disorder caused by mutations of sodium channel Na1.7, a peripheral channel expressed within dorsal root ganglion and the sympathetic ganglion neurons. Clinically, IEM is characterised by paroxysmal attacks of severe pain, usually in the distal extremities, triggered by warmth or exercise. Pain is not adequately treated by existing pharmacological agents. Individuals with IEM classically cool their limbs for relief, in some cases resulting in tissue injury. We describe a patient from a family with IEM due to the L858F mutation of Na1.7 who presented with refractory hypothermia due to overcooling. This presentation of refractory hypothermia necessitating warming strategies, complicated by severe warmth-induced pain, posed a substantial therapeutic challenge. We report our experience in overcoming hypothermia lasting 3 weeks in a child with IEM, discuss possible pathophysiological mechanisms underlying this unusual complication and suggest potential therapeutic interventions.
遗传性红斑性肢痛症(IEM)是一种已被充分描述的疼痛性疾病,由钠通道Na1.7突变引起,Na1.7是一种在背根神经节和交感神经节神经元中表达的外周通道。临床上,IEM的特征是严重疼痛的阵发性发作,通常发生在远端肢体,由温暖或运动引发。现有药物不能充分治疗疼痛。IEM患者通常会让四肢降温以缓解疼痛,在某些情况下会导致组织损伤。我们描述了一名来自一个因Na1.7基因L858F突变而患IEM家庭的患者,该患者因过度降温出现难治性体温过低。这种难治性体温过低的表现需要采取升温策略,同时伴有严重的热诱导疼痛,这带来了巨大的治疗挑战。我们报告了我们在一名患有IEM的儿童中克服持续3周体温过低的经验,讨论了这种不寻常并发症潜在的病理生理机制,并提出了潜在的治疗干预措施。